Anish Ray

473 total citations
40 papers, 252 citations indexed

About

Anish Ray is a scholar working on Oncology, Immunology and Infectious Diseases. According to data from OpenAlex, Anish Ray has authored 40 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 10 papers in Immunology and 9 papers in Infectious Diseases. Recurrent topics in Anish Ray's work include Histiocytic Disorders and Treatments (7 papers), Parvovirus B19 Infection Studies (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Anish Ray is often cited by papers focused on Histiocytic Disorders and Treatments (7 papers), Parvovirus B19 Infection Studies (7 papers) and Acute Lymphoblastic Leukemia research (7 papers). Anish Ray collaborates with scholars based in United States, United Kingdom and Denmark. Anish Ray's co-authors include Winston W. Huh, Dan S. Gombos, Srinivas S. Somanchi, Dean A. Lee, Lisa M. Kopp, Riyaz Basha, Vladimir Senyukov, Shiguo Zhu, Cecele J. Denman and Lester A. H. Critchley and has published in prestigious journals such as SHILAP Revista de lepidopterología, Lara D. Veeken and Nutrition.

In The Last Decade

Anish Ray

33 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anish Ray United States 9 68 57 54 51 50 40 252
Shoko Nakayama Japan 9 91 1.3× 69 1.2× 34 0.6× 19 0.4× 26 0.5× 42 267
Satoru Yonekura Japan 9 100 1.5× 32 0.6× 98 1.8× 39 0.8× 56 1.1× 28 282
Cengiz Canpolat Türkiye 10 25 0.4× 40 0.7× 45 0.8× 33 0.6× 60 1.2× 29 223
Ozan Salim Türkiye 11 52 0.8× 49 0.9× 44 0.8× 35 0.7× 11 0.2× 46 271
Mahmood M. T. M. Ally South Africa 9 30 0.4× 55 1.0× 45 0.8× 27 0.5× 17 0.3× 23 316
Alexandre Karras France 7 51 0.8× 50 0.9× 39 0.7× 23 0.5× 145 2.9× 14 315
César Díaz‐López Spain 10 26 0.4× 55 1.0× 39 0.7× 58 1.1× 14 0.3× 17 269
Blanca Molina Spain 11 100 1.5× 92 1.6× 44 0.8× 32 0.6× 66 1.3× 31 346
Te‐Kau Chang Taiwan 12 24 0.4× 29 0.5× 77 1.4× 62 1.2× 38 0.8× 26 298
Takeshi Umibe Japan 9 29 0.4× 66 1.2× 18 0.3× 18 0.4× 89 1.8× 17 262

Countries citing papers authored by Anish Ray

Since Specialization
Citations

This map shows the geographic impact of Anish Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anish Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anish Ray more than expected).

Fields of papers citing papers by Anish Ray

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anish Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anish Ray. The network helps show where Anish Ray may publish in the future.

Co-authorship network of co-authors of Anish Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Anish Ray. A scholar is included among the top collaborators of Anish Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anish Ray. Anish Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vallance, Kelly, et al.. (2025). Targeted Therapy in Pediatric Langerhans Cell Histiocytosis: Describing a Novel Strategy to Minimize Long‐Term Exposure While Maintaining Efficacy. Pediatric Blood & Cancer. 72(11). e32016–e32016. 1 indexed citations
2.
Ray, Anish, et al.. (2025). Life-threatening Lymphatic Malformation With Somatic Activating NRAS Mutation Successfully Treated With Trametinib: A Case Study. Journal of Pediatric Hematology/Oncology. 47(2). e104–e106.
3.
Naymagon, Leonard, Philip Roehrs, Michelle L. Hermiston, et al.. (2025). Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH). Orphanet Journal of Rare Diseases. 20(1). 200–200. 4 indexed citations
4.
Ray, Anish, et al.. (2024). Precision Medicine for Acute Lymphoblastic Leukemia in Children: A Review. Children. 11(11). 1329–1329.
5.
Vila, Josephine, et al.. (2024). P024 Dermatomyositis, a blurred clinical picture. Lara D. Veeken. 63(Supplement_1).
6.
Liu, Angela, et al.. (2023). Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care. SHILAP Revista de lepidopterología. 15(2). 244–255. 6 indexed citations
7.
Kim, Hee Jung, Anish Ray, Douglas Fair, et al.. (2023). Strategies for the Treatment of Infantile Soft Tissue Sarcomas With BCOR Alterations. Journal of Pediatric Hematology/Oncology. 45(6). 315–321. 3 indexed citations
8.
Hamby, Tyler, et al.. (2023). Utilization of Genomic Tumor Profiling in Pediatric Liquid Tumors: A Clinical Series. SHILAP Revista de lepidopterología. 15(2). 256–265. 1 indexed citations
9.
Khimani, Farhad, et al.. (2022). Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19. SHILAP Revista de lepidopterología. 10. 100126–100126. 1 indexed citations
10.
Khimani, Farhad, et al.. (2022). The mechanistic basis linking cytokine storm to thrombosis in COVID-19. SHILAP Revista de lepidopterología. 8. 100110–100110. 8 indexed citations
11.
12.
Heym, Kenneth, et al.. (2021). Multidisciplinary Multiagent Treatment of Complex Lymphatic Anomalies with Severe Bone Disease: A Single-Site Experience. Lymphatic Research and Biology. 20(2). 118–124. 2 indexed citations
13.
Liu, Angela & Anish Ray. (2021). An unusual case of late recurrence of bilateral retinoblastoma. Bone Reports. 15. 101135–101135.
14.
Hamby, Tyler, et al.. (2020). Prevalence and predictors of weight loss during induction therapy for childhood acute lymphoblastic leukemia. Nutrition. 81. 110937–110937. 4 indexed citations
15.
Sankpal, Umesh T., Don Eslin, W. Paul Bowman, et al.. (2019). Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells. APOPTOSIS. 24(1-2). 21–32. 5 indexed citations
16.
Ray, Anish, et al.. (2018). Mixed Nonseminomatous Germ Cell Tumor with Rhabdomyosarcomatous Malignant Transformation in a Pediatric Patient. Indian Journal of Medical and Paediatric Oncology. 39(2). 250–253. 3 indexed citations
17.
Sankpal, Umesh T., et al.. (2016). Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth. Investigational New Drugs. 35(2). 158–165. 22 indexed citations
18.
Ray, Anish & Winston W. Huh. (2012). Current State-of-the-Art Systemic Therapy for Pediatric Soft Tissue Sarcomas. Current Oncology Reports. 14(4). 311–319. 23 indexed citations
19.
Ray, Anish & Dan S. Gombos. (2012). Retinoblastoma: An Overview. The Indian Journal of Pediatrics. 79(7). 916–921. 21 indexed citations
20.
Leonard, Robert, et al.. (1997). Tamoxifen toleration and toxicity. Endocrine Related Cancer. 4(3). 245–249. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shoko Nakayama Breakdown of academic impact, for papers by Satoru Yonekura Breakdown of academic impact, for papers by Cengiz Canpolat Breakdown of academic impact, for papers by Ozan Salim Breakdown of academic impact, for papers by Mahmood M. T. M. Ally Breakdown of academic impact, for papers by Alexandre Karras Breakdown of academic impact, for papers by César Díaz‐López Breakdown of academic impact, for papers by Blanca Molina Breakdown of academic impact, for papers by Te‐Kau Chang Breakdown of academic impact, for papers by Takeshi Umibe
Rankless by CCL
2026